Estrogen and progesterone attenuate glutamate neurotoxicity via regulation of EAAT3 and GLT-1 in a rat model of ischemic stroke

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 268

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-23-10_015

تاریخ نمایه سازی: 19 دی 1399

Abstract:

Objective(s): Glutamate is the most widespread neurotransmitter in the central nervous system and has several functions as a neuromodulator in the brain although in pathological conditions like ischemia it is excessively released causing cell death. Under physiological conditions, glutamate is rapidly scavenged from the synaptic cleft by excitatory amino-acid transporters (EAATs). An imbalance in glutamatergic neurotransmission could influence the expression of glutamate transporters and is a pathological feature in several neurological disorders. It has been shown that estrogen and progesterone act as neuroprotective agents after brain injury. This study aims to investigate the role of hormone therapy after middle cerebral artery occlusion (tMCAO) in the expression of GLT-1 and EAAT3 as glutamate transporters.Materials and Methods: Middle cerebral artery occlusion technique was performed in Wistar rats in order to induce focal cerebral ischemia. Estrogen, progesterone, and a combination of both hormones were injected subcutaneously in the early minutes of reperfusion. Sensorimotor functional tests were performed and infarct volume was calculated by TTC staining of brain section. Gene and protein expression of EAAT3 and GLT-1 were evaluated by RT-PCR, immunoblotting, and immunohistochemistry. Results: Behavioral scores were increased and infarct volume was reduced by hormone therapy. RT-PCR, immunoblotting, and immunohistochemistry data showed that the expression of GLT-1 and EAAT3 increased after ischemia. Also, estrogen and progesterone treatment enhanced mRNA and protein expression levels of GLT-1 and EAAT3 compared with ischemia.Conclusion: Steroids may protect brain tissue against ischemia-induced tissue degeneration by decreasing extracellular glutamate levels through the induction of glutamate transporters.

Keywords:

EAAT3 Estrogen GLT , 1 Glutamate transporter Progesterone tMCAO

Authors

Sara Nemati Pour

Anatomical Sciences Research Center, Institute for Basic Sciences,Kashan University of Medical Sciences, Kashan, Iran

Zeinab Vahidinia

Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Majid Nejati

Anatomical Sciences Research Center, Institute for Basic Sciences,Kashan University of Medical Sciences, Kashan, Iran

Homayon Naderian

Anatomical Sciences Research Center, Institute for Basic Sciences,Kashan University of Medical Sciences, Kashan, Iran

Cordian Beyer

Institute of Neuroanatomy, Faculty of Medicine, RWTH Aachen University, Aachen, Germany

Abolfazl Azami Tameh

Anatomical Sciences Research Center, Institute for Basic Sciences,Kashan University of Medical Sciences, Kashan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry ...
  • 2.    Lin Y, Zhang J-C, Fu J, Chen F, Wang ...
  • 3.    Hou S-W, Wang Y-Q, Xu M, Shen D-H, Wang ...
  • 4.    Krafft PR, Bailey EL, Lekic T, Rolland WB, Altay ...
  • 5.    Wu J-y, Li M, Cao L-j, Sun M-l, Chen ...
  • 6.    Vahidinia Z, Tameh AA, Nejati M, Beyer C, Talaei ...
  • 7.    Mirzaei H. Stroke in women: risk factors and clinical ...
  • 8.    Nejati M, Atlasi MA, Karimian M, Nikzad H, Tameh ...
  • 9.    Krzyżanowska W, Pomierny B, Filip M, Pera J. Glutamate ...
  • 10.    Kim K, Lee SG, Kegelman TP, Su ZZ, Das ...
  • 11.    Maragakis NJ, Dykes‐Hoberg M, Rothstein JD. Altered expression of ...
  • 12.    Hazell AS. Excitotoxic mechanisms in stroke: an update of ...
  • 13.    Campos F, Sobrino T, Ramos-Cabrer P, Argibay B, Agulla ...
  • 14.    Divito CB, Underhill SM. Excitatory amino acid transporters: roles ...
  • 15.    Tameh AA, Clarner T, Beyer C, Atlasi MA, Hassanzadeh ...
  • 16.    Kostandy BB. The role of glutamate in neuronal ischemic ...
  • 17.    Papadia S, Soriano FX, Léveillé F, Martel M-A, Dakin ...
  • 18.    Pawlak J, Brito V, Küppers E, Beyer C. Regulation ...
  • 19.    Benchoua A, Guégan C, Couriaud C, Hosseini H, Sampaı̈o ...
  • 20.    Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition ...
  •  21.    Strom JO, Theodorsson E, Holm L, Theodorsson A. Different ...
  • 22.    Kipp M, Beyer C. Impact of sex steroids on ...
  • 23.    Kipp M, Amor S, Krauth R, Beyer C. Multiple ...
  • 24.    Duportets L, Maria A, Vitecek S, Gadenne C, Debernard ...
  • 25.    Saleh TM, Connell BJ, Legge C, Cribb AE. Estrogen ...
  • 26.    Cai W, Zhu Y, Furuya K, Li Z, Sokabe ...
  • 27.    Suzuki S, Brown CM, Wise PM. Neuroprotective effects of ...
  • 28.    Zhang Q-G, Raz L, Wang R, Han D, De ...
  • 29.    Dang J, Mitkari B, Kipp M, Beyer C. Gonadal ...
  •  30.    Liang Z, Valla J, Sefidvash‐Hockley S, Rogers J, Li ...
  • 31.    Gazzaley AH, Weiland NG, McEwen BS, Morrison JH. Differential ...
  •  32.    Butchbach ME, Tian G, Guo H, Lin C-lG. Association ...
  •  33.    Hernández-Jiménez M, Martínez-López D, Gabandé-Rodríguez E, Martín-Segura A, Lizasoain ...
  • 34.    Nejati M, Tameh AA, Vahidinia Z, Atlasi MA. Mesenchymal ...
  • 35.    Vahidinia Z, Alipour N, Atlasi MA, Naderian H, Beyer ...
  • 36.    Nejati M, Tameh AA, Atlasi MA. Role of toll‐like ...
  •     37.    Lammerding L, Slowik A, Johann S, Beyer C, ...
  • 38.    Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. ...
  • 39.    Pradillo J, Hurtado O, Romera C, Cardenas A, Fernandez-Tome ...
  • 40.    Krzyżanowska W, Pomierny B, Bystrowska B, Pomierny-Chamioło L, Filip ...
  • 41.    Amantea D, Russo R, Bagetta G, Corasaniti MT. From ...
  • 42.    Luoma JI, Kelley BG, Mermelstein PG. Progesterone inhibition of ...
  • 43.    Carwile E, Wagner AK, Crago E, Alexander SA. Estrogen ...
  • 44.    Hoffman GE, Merchenthaler I, Zup SL. Neuroprotection by ovarian ...
  • 45.    Tameh AA, Karimian M, Zare-Dehghanani Z, Aftabi Y, Beyer ...
  • 46.    Lee E, Sidoryk-Wêgrzynowicz M, Wang N, Webb A, Son ...
  • 47.    Arranz AM, Gottlieb M, Perez-Cerda F, Matute C. Increased ...
  • 48.    Bruhn T, Levy LM, Nielsen M, Christensen T, Johansen ...
  • 49.    Azcoitia I, Barreto GE, Garcia-Segura LM. Molecular mechanisms and ...
  • 50.    Gottlieb M, Domercq M, Matute C. Altered expression of ...
  • 51.    Cimarosti H, Jones NM, O’Shea RD, Pow DV, Salbego ...
  • 52.    Dawson L, Djali S, Gonzales C, Vinegra M, Zaleska ...
  • 53.    Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang ...
  • 54.    Ganel R, Ho T, Maragakis NJ, Jackson M, Steiner ...
  • 55.    Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan ...
  • 56.    Cimarosti H, O’Shea RD, Jones NM, Horn AP, Simão ...
  • 57.    Lee S-A, Choi J-G, Zuo Z. Volatile anesthetics attenuate ...
  • 58.    Dringen R, Hirrlinger J. Glutathione pathways in the brain. ...
  •  59.    Marí M, Morales A, Colell A, García-Ruiz C, Fernández-Checa ...
  • 60.    Anderson MF, Sims NR. The effects of focal ischemia ...
  • 61.    Yabuki Y, Fukunaga K. Oral administration of glutathione improves ...
  • 62.    Lewerenz J, Maher P. Control of redox state and ...
  • نمایش کامل مراجع